The Cervical Cancer Vaccine offers long-lasting protection against the most common cancer-causing strains of the human papillomavirus (HPV). Current research shows that the vaccine provides strong immunity for at least 10 to 12 years after completing the full vaccination schedule, and protection may last even longer. Studies have found that antibody levels remain high and effective over time, reducing the risk of HPV infection and cervical cancer.
While there is no evidence that a booster dose is needed yet, ongoing research continues to monitor the duration of immunity. Getting the Cervical Cancer Vaccine at the recommended age—usually between 9 and 26 years—ensures maximum protection before potential exposure to HPV. Regular cervical screenings are still important, as the vaccine does not cover all HPV types.